Benzinga | Nov 10, 2020 08:15AM EST

Raymond James Initiates Coverage On Tarsus Pharmaceuticals with Strong Buy Rating, Announces Price Target of $39

Raymond James initiates coverage on Tarsus Pharmaceuticals (NASDAQ:TARS) with a Strong Buy rating and announces Price Target of $39.